AGP Executive Report
Last update: 36 minutes agoHepatitis B Trial Halted: A researcher says a controversial US-backed study in Guinea-Bissau will not proceed because the government did not grant the necessary approval. The trial would have delayed hepatitis B vaccination for thousands of newborns, drawing ethical objections from the WHO and others. Vaccine Seizure: Judicial police raided the Bandim Health Project and seized vaccine doses as part of an investigation. Officials stressed that the seizure does not indicate problems with vaccine quality, safety or effectiveness. Newborn Protection: Guinea-Bissau plans to introduce universal hepatitis B vaccination at birth in 2028; health experts say getting the proven vaccine to every newborn sooner should remain a priority.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.